TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02761863 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study NCT02761863 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03678506 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02443818 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05134376 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00533949 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03750396 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01837589 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04342312 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT02095691 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00612066 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03537378 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04527263 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06266598 — Predictive Biomarker (PRD): AZGP1 mRNA
Genes: AZGP1; ZAG; ZNGP1
Study NCT06266598 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT06156917 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT06156917 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT00036946 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02014883 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study NCT02021864 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01657201 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT02011685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00006185 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02178943 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT01566981 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02348138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03309436 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02847000 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02847000 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT02670187 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00121771 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT01889615 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study NCT02505009 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02690441 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT01045382 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00523471 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT03745846 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01807130 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00503841 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00503841 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00503841 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03371823 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT03371823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03454594 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05027191 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05027191 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05027191 — Safety Biomarker (SAF): Alpha-glutathione S-transferase
Study NCT03259399 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02351713 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00857194 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00857194 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02409342 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00001967 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03271190 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00005834 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02709876 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01582191 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01582191 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT01234337 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02282423 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT00830180 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00468507 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT04069533 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study NCT02698501 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT03616418 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05380128 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03458728 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05417191 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT04367090 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04083157 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT01521377 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03424603 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study NCT01201226 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01201226 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00089206 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03569644 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT00229684 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00229684 — Safety Biomarker (SAF): Urinary total protein
Study NCT00381797 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00381797 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02002520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02203019 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00848224 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04329546 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00695318 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03151161 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03151161 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01054339 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT00004039 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04491864 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT00486668 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00364923 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04023032 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03757065 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT04303806 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04303806 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03005496 — Predictive Biomarker (PRD): TICAM1 mRNA
Genes: TICAM1; PRVTIRB; TRIF
Study NCT03504631 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03503968 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT03503968 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT02878369 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02990663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02535767 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT00765154 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04266353 — Predictive Biomarker (PRD): IGF2 mRNA
Genes: IGF2; PP1446
Study NCT04557046 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03893227 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01787864 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01787864 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT02785731 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT01098708 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03793114 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04587323 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02207868 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03217890 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT04371692 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00001644 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04439318 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04439318 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT04439318 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study NCT03055234 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04597073 — Predictive Biomarker (PRD): OSM mRNA
Genes: OSM
Study NCT04597073 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT04597073 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT02113358 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02113358 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT03036618 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02367105 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02014961 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study NCT01225211 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02339792 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT02823925 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study NCT02442765 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT03565835 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01686282 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02859441 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02859441 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT02964767 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00913926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01900743 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT01182103 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01182103 — Safety Biomarker (SAF): BDNF
Study NCT01287819 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03304756 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00659230 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study NCT02842333 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT02924766 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03725566 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00784147 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04558801 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02997982 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT01163734 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03208166 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02468349 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03708666 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00501410 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00277017 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00005946 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01476033 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02798172 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT01882868 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01882868 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00995449 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02589535 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02589535 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT00034281 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01508091 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT01508091 — Predictive Biomarker (PRD): UCP3 mRNA
Genes: UCP3; SLC25A9
Study NCT01508091 — Predictive Biomarker (PRD): SIRT6 mRNA
Genes: SIRT6; SIR2L6
Study NCT01508091 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04321460 — Predictive Biomarker (PRD): Leucine-rich alpha-2-glycoprotein
Genes: LRG1; LRG
Study NCT02725567 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02725567 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT03350906 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00426478 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01328210 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04267081 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT02795325 — Predictive Biomarker (PRD): PHC1 mRNA
Genes: PHC1; EDR1; PH1
Study NCT03749499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00718393 — Predictive Biomarker (PRD): SLC1A2 mRNA
Genes: SLC1A2; EAAT2; GLT1
Study NCT00718393 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05394090 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT05394090 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT05394090 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02646891 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04473664 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00219960 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04327934 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02136147 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study NCT03167177 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04195932 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04195932 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04195932 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02019680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04657562 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00386360 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04079933 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT04508803 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04508803 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT04508803 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT04508803 — Predictive Biomarker (PRD): BARD1 mRNA
Genes: BARD1
Study NCT04508803 — Predictive Biomarker (PRD): BLM mRNA
Genes: BLM; RECQ2; RECQL3
Study NCT04508803 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT04508803 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study NCT04508803 — Predictive Biomarker (PRD): FANCD2 mRNA
Genes: FANCD2; FACD
Study NCT04508803 — Predictive Biomarker (PRD): FANCE mRNA
Genes: FANCE; FACE
Study NCT04508803 — Predictive Biomarker (PRD): FANCF mRNA
Genes: FANCF
Study NCT04508803 — Predictive Biomarker (PRD): FANCM mRNA
Genes: FANCM; KIAA1596
Study NCT04508803 — Predictive Biomarker (PRD): NBN mRNA
Genes: NBN; NBS; NBS1; P95
Study NCT04508803 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04508803 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study NCT01498562 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02827032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02382523 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03468582 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02774109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01085383 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01398462 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT02626442 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04422977 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02124200 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02455908 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03978663 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00115336 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00010335 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03615170 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00302926 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00302926 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02081937 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02081937 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT03016832 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT01705678 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01705678 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00898391 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT01440413 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00389675 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03471364 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03471364 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02710110 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04412447 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT01276873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02062099 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT01304927 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT01304927 — Predictive Biomarker (PRD): CYP2R1 mRNA
Genes: CYP2R1
Study NCT01304927 — Predictive Biomarker (PRD): CYP27A1 mRNA
Genes: CYP27A1; CYP27
Study NCT01304927 — Predictive Biomarker (PRD): CYP27B1 mRNA
Genes: CYP27B1; CYP1ALPHA; CYP27B
Study NCT01304927 — Predictive Biomarker (PRD): CYP24A1 mRNA
Genes: CYP24A1; CYP24
Study NCT02653989 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04382794 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01304407 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00715858 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00715858 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01065831 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01702129 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01702129 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00479479 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03437824 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02854618 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00678028 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT03690843 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT01854957 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00113048 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT04545710 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00006494 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00006494 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03120624 — Predictive Biomarker (PRD): SLC5A5 mRNA
Genes: SLC5A5; NIS
Study NCT00850629 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids